UK Innovation & Science Seed Fund News

UK. 12 October 2009 – Mike Romanos has been appointed Chief Scientific Officer of Crescendo Biologics (“Crescendo”) and joins the Board as a Director. Dr Romanos will take leadership of the company and its proprietary antibody fragment technologies following a £4.5 million seed fundraising round led by Sofinnova Partners (see separate announcement). Dr Romanos has […]

read more

1 45 46 47